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γδ T cells play an important role in regulating the immune response to stress stimuli; however, the mean by which these innate
lymphocytes fulﬁll this function remains poorly deﬁned. The main subset of human peripheral blood γδ T cells responds to
nonpeptidic antigens, such as isopentylpyrophosphate (IPP), a metabolite in the mevalonate pathway for both eukaryote and
prokaryote cells. IPP-primed γδ T cells signiﬁcantly augment the inﬂammatory response mediated by monocytes and αβ Tc e l l s
to TSST-1, the staphylococcal superantigen that is the major causative agent of toxic shock syndrome. Here we show that the small
pool of activated peripheral γδ T cells induces an early upregulation of CD40 on monocytes and the local release of High Mobility
Group Box-1 (HMGB-1), the molecule designated as the late mediator of systemic inﬂammation. This ﬁnding provides a new
basis for how γδ T cells may serve as inﬂuential modulators of both endogenous and exogenous stress stimuli.
Copyright © 2009 S. Kalyan and A. W. Chow. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
1.Introduction
γδ T cells have a nonredundant role in regulating immune
homeostasis. In comparison to αβ T cells, they lack receptor
diversityyetdemonstrateremarkableplasticityinresponseto
both infectious and noninfectious stimuli. As an extension
of their dichotomous nature, γδT cells have been held
liable for both instigating over-zealous immune responses
[1–3] as well as reigning in inﬂammation by controlling
activated macrophages and promoting wound healing [4–
6]. In humans, the main subset of peripheral blood γδT
cells usually comprises between 1 and 5% of circulating T
cells and bears the canonical Vγ9Vδ2T cell receptor. These
Vγ9Vδ2T cells are unique to primates, and they respond
to endogenous and exogenous stress-induced molecules that
are nonpeptidic in nature and preclude the requirement
for processing or presentation by classical MHC molecules
[7–9]. Isopentylpyrophosphate (IPP) is the prototypical
phosphoantigen recognized by Vγ9Vδ2T cells that was
ﬁrst isolated from lysates of mycobacteria [7]. It was later
determined to be a metabolite in the mevalonate pathway
in all eukaryotic and some prokaryotic cells, including
Staphylococcus aureus [10, 11]. During the initial phase of
infection with low bacterial inocula of S. aureus,V γ9Vδ2T
cells are activated by endogenous mevalonate metabo-
lites through the accumulation and dephosphorylation of
the hydroxymethylglutaryl-coenzyme A reductase, the rate-
limiting enzyme of the mevalonate pathway [11]. Therefore,
primates have evolved the ability to readily respond to
bacterial infection as well as endogenous damage by sensing
the dysregulation of the mevalonate pathway, which may be
considered a stress-associated “alarmin” for these primordial
lymphocytes.
We have shown that stimulating the small pool of human
γδT cells present in PBMC with IPP markedly augmented
the early proinﬂammatory response to Toxic Shock Syn-
drome Toxin-1 (TSST-1) [3]. TSST-1 is a staphylococcal
superantigen that exerts a potent inﬂammatory response
by bridging Vβ2s p e c i ﬁ cαβT cell receptors with conserved
regions of the MHC class II molecules of antigen presenting
cells (APCs) outside the peptide-binding groove [12]. Ferry
et al. [13] demonstrated the presence of speciﬁc VβT
cell signatures of various superantigenic toxins, including
TSST-1, in the blood of patients with staphylococcal TSS.
We previously demonstrated that IPP-activated γδTc e l l s
augment the levels of proinﬂammatory cytokines within2 Mediators of Inﬂammation
the ﬁrst 6 hours post-TSST-1 treatment, thereby changing
the kinetics and magnitude of the immune response to the
superantigen [3]. We have also shown that High Mobility
Group Box Protein-1 (HMGB-1) is released following TSST-
1 stimulation [14]. HMGB-1 is a highly conserved nonhis-
tone DNA-binding protein found in virtually all nucleated
cells and is regarded as being the late mediator of sepsis
[15]. Activated monocytes secrete HMGB-1 after exposure
to endotoxin [16], and it is detectable in the serum of
septic patients within 24 hours. Importantly, neutralizing
the eﬀects of HMGB-1 at this late time point, either by
anti-HMGB-1 antibodies or antagonists, rescued mice from
sepsis-induced mortality [15]. In contrast to endotoxin,
which activates only macrophages to secrete HMGB-1,
both T cells and macrophages participate in the nuclear
translocation and subsequent release of HMGB-1 into
the extracellular environment following TSST-1 stimulation
[14].
The ﬁrst aim of the present study was to evaluate the
inﬂuence exerted by IPP-primed Vγ9Vδ2T cells on the
change in costimulatory molecule expression that could
explain their ability to enhance the immune response to
TSST-1. The second objective was to determine the conse-
quence of γδ T cell mediated immune modulation on the
expression and secretion of HMGB-1.
2.MaterialsandMethods
2.1. Toxin Puriﬁcation. Recombinant TSST-1 was puriﬁed
from culture supernatants of S. aureus strain RN4220
previously transformed to carry the tst gene, using both
preparative isoelectric focusing and chromatofocusing [17].
Toxin purity was assessed by silver staining after sodium
dodecyl sulfate-polyacrylamide gel electrophoresis on 14%
acrylamide gels, and LPS activity was undetectable by
the Limulus amoebocyte lysate gelation (sensitivity limit,
10pg/mL).
2.2. Preparation of Cells and Culture Conditions. Fresh
human peripheral blood mononuclear cells (PBMC) from
healthy donors were obtained by Ficoll-Paque PLUS (Amer-
sham Biosciences Corp., Piscataway, NJ) density centrifuga-
tion, and cultured in 96-well U-bottom plates at 1.5 × 106
cells/ml in complete culture medium consisting of RPMI
1640 (StemCell Technologies Inc., Vancouver, BC, Canada),
10% heat-inactivated fetal bovine serum (HyClone Labo-
ratories Inc., Logan, UT), 2mM L-glutamine (StemCell),
25mM Hepes buﬀer (StemCell), and 2ug/ml of polymyxin
B sulphate (Sigma-Aldrich Corp., St. Louis, MO). Depletion
of γδ T cells was accomplished by immunomagnetic positive
cellselectionwithananti-γδ TCRMAb(cloneImmu510,BD
BioSciences Pharmingen Inc., San Diego, CA) conjugated to
an antidextran MAb tetramer (StemCell), which left the rest
of the PBMC untouched, using the StemSep protocol (Stem-
Cell). Purity of the γδ T cell-depleted PBMC was analyzed by
ﬂow cytometry using phycoerythrin-(PE-) conjugated anti-
Vδ2 antibody (BD BioSciences Pharmingen). Figure 1 shows
the population of Vγ9Vδ2 T cells in PBMCs before (which
made up 1.5% of live cells) and after depletion (0.1%).
2.3. Treatment of PBMC with IPP and TSST-1. PBMCs with
or without γδ T cell depletion were treated with either 45μM
IPP (Sigma-Aldrich) or left untreated in complete growth
medium for 16–18 hours (overnight) at 37◦C, 5% CO2
prior to treatment with 1nM TSST-1. For secreted HMGB-
1 detection, culture supernatants were microcentrifuged at
800 ×gf o r5m i n u t e sa n df r o z e na t−70◦C until analysis.
2.4. Flow Cytometric Analysis of Surface-Expressed HMGB-
1o nD i ﬀerentiated Cells and Expression of Costimulatory
Molecules. Surface expressed HMGB-1 was analyzed by
ﬂow cytometry (FACSCalibur Flow Cytometry System, BD
BioSciences Pharmingen) using the anti-HMGB-1 antibody
and secondary Alexa488-conjugated antibody (as described
below). Costimulatory molecule cell surface expression was
performed by incubating cells at 4◦C( p r o t e c t e df r o m
light) for 30 minutes with the following ﬂuorescently-
conjugatedantibodies:APCantihumanHLA-DR(LN3),PE-
Cy5 anti-human CD86 (B7-2) (eBioscience, Inc), FITC anti-
CD40 (5C3), PE-Cy5 anti-CD80 (B7-1), PE-Cy5 anti-CD28
(CD28.2), and APC anti-CD25 (M-A251) (BD Biosciences,
PharMingen). Cells were subsequently washed, resuspended
in buﬀer containing 2mM EDTA (to facilitate detachment of
adherent cells), and transferred to FACS to analyze by ﬂow
cytometry (a minimum of 10 000 events were collected).
2.5. Fluorescent Microscopy Analysis. Surface expression of
HMGB-1 on PBMC by ﬂuorescent microscopy has been
previously described in detail [14]. In brief, PBMCs were
cultured (37◦C, 5% CO2) directly on sterile cover slips
to allow attachment of adherent cells overnight before
stimulation with 1nM of TSST-1. For HMGB-1 expression,
cells were incubated with rabbit anti-human HMGB-1 IgG
as previously described [14], diluted in blocking buﬀer (PBS,
3% FBS), followed by a secondary Alexa488-conjugated
goat antirabbit IgG antibody. Cells were subsequently ﬁxed
using Cytoﬁx buﬀer (Pharmingen). Fluorescently labelled
PBMCs were then stained with Hoechst 3342 nuclear dye
(Molecular Probes) according to manufacturer’s directions,
and mounted on slides using Prolong Anti-Fade reagent
(M olecularP robes).CellswerevisualizedwithanAxioPlanII
ﬂuorescence microscope equipped with a CCD camera using
Northern Eclipse software (Epix) for acquisition of images.
Images were taken with the 63 x oil immersion objective
lens, and Adobe Photoshop 6.0 software was used for image
layout.
2.6. Western Blot Analysis of Secreted HMGB-1. PBMC
culture supernatants were concentrated (∼10-fold) from the
original volume of 1.5ml using Amicon Ultra centrifugal
ﬁlters with a molecular weight cutoﬀ of 10 kDa (Milli-
pore). The supernatants then had been further prepared
using the SDS-PAGE Clean-up kit (Amersham) according
to the manufacturer’s directions prior to running on a
12% polyacrylamide gel. Western blotting was performed
by semidry transfer of proteins (Trans-Blot SD Semi-Dry
Electrophoretic Transfer Cell, BioRad) onto an Immobilon-
P PVDF membrane (Millipore) which was blocked for 1



























































Figure 1: Flow cytometry plot showing a representative population of γδ T cells present in human PBMCs. Before depletion by magnetic
bead separation, γδ T cells constituted ∼1.5% of PBMC (a) and < 0.1% after depletion (b).
prior to overnight incubation (at 4◦C) with rabbit polyclonal
anti-HMGB-1 antibody. The membrane was subsequently
incubated with anti-rabbit IgG horse-radish-peroxidase-
(HRP-) conjugated secondary antibody for 1 hour at room
temperature on a shaker. HMGB-1 detection was performed
usingSuperSignalsubstrate(Pierce)anddevelopedaswellas
analyzed using the Alpha Innotech 3400 Gel Documentation
system (Alpha Innotech).
2.7. Statistical Analysis. Statistical analysis was performed
using Prism 4.0 software package (GraphPad Software, Inc.,
San Diego, CA). Student t-tests (one-tail) were used to
assess the signiﬁcance of diﬀerences in HMGB-1 and co-
stimulatory molecule expression between IPP treated and
untreated PBMC at diﬀerent times post-TSST-1 stimulation.
The eﬀects of IPP over time on co-stimulatory molecule
expression by APC (CD40, CD80, CD86, HLA-DR) and
αβ T cells (CD25, CD28) were further examined by 2-
way ANOVA. Diﬀerences were considered signiﬁcant if the
probability of the null hypothesis was less than ﬁve percent
(P<. 05). Each experiment represents 3 to 4 healthy subjects
unless otherwise noted.
3. Results
3.1. IPP-Primed γδ T Cells Induce an Early Upregulation
of CD40 following TSST-1 Stimulation. Following overnight
treatment with IPP, CD40 expression was upregulated in
comparison to those that were untreated (IPP + TSST-1
versus TSST-1 alone; P<. 05, Student’s t-test) (Figure 2(a)).
The elevated CD40 expression was observed up to 6 hours
postsuperantigen stimulation, after which time CD40 was
downregulated or internalized. We previously demonstrated
that CD40L (CD154) is expressed on T cells within 3 hours
following exposure to TSST-1 [18], therefore, the down-
regulation of CD40 beyond 6 hours is likely a consequence
of CD40 binding to CD40L on TSST-1-activated T cells.
We veriﬁed that up-regulation of CD40 expression in
populations exposed to IPP was solely attributed to the
presence of activated γδ T cells, since removal of γδ T
cells completely abrogated the eﬀect of IPP (Figure 2(b)).
The eﬀect of IPP-activated γδ Tc e l l so v e rt i m eo nC D 4 0
expression following TSST-1 stimulation was further veriﬁed
using 2-way ANOVA (IPP x time interaction, P<. 05).
In contrast to CD40, the expression of CD86 was down-
regulated early in IPP treated PBMC at 3 hours following
TSST-1 stimulation (IPP + TSST-1 versus TSST-1 alone;
P<0.05, Student’s t-test) (Figure 2(a)). Again, this eﬀect
wasabrogatedfollowingdepletionofγδ Tcells(Figure 2(b)).
Two-wayANOVAconﬁrmedaninteractioneﬀect(IPPxtime
interaction, P<. 05). There was a similar trend for decreased
expression of HLA-DR (the MHC class II molecule to which
TSST-1 binds on APC) and CD80 by IPP treatment, but the
diﬀerences were not statistically signiﬁcant.
3.2. TSST-1, but Not IPP-Primed γδ TC e l l s ,A c t i v a t eαβ T
Cells. In contrast to the direct aﬀect of IPP on monocyte
function, there was little notable direct inﬂuence on the
activation state of αβ T cells as evaluated by the expression
of CD25 or CD28, which remained largely unchanged in
response to IPP pretreatment (Figure 3). The upregulation
of CD25 on αβ T cells at 24 hours was solely dependent
on TSST-1 stimulation regardless of IPP, as shown by the
comparison of IPP + TSST-1 versus IPP alone (P = .001,
Student’s t-test, Figure 3). Two-way ANOVA conﬁrmed this
eﬀect (TSST-1 eﬀect, P<. 01; TSST-1 x time interaction,
P<. 005).
3.3. IPP-Primed γδ T Cell Potentiates the Release of Cell Sur-
face Expression of HMGB-1 (Amphoterin) into the Extracel-
lular Milieu following TSST-1 Stimulation. Rouhiainen et al.
established that monocytes that had become adherent export4 Mediators of Inﬂammation
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Figure 2: Continued.Mediators of Inﬂammation 5
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Figure 2: Modulation of CD40, CD86, HLA-DR and CD80 on APCs by IPP-activated γδ Tc e l l s . PBMC were cultured overnight in the
presence of IPP or absence of IPP before stimulation with 1nM of TSST-1 (a). Data (mean ± SEM) for expression of CD40, CD86, HLA-DR
and CD80 were shown after various time intervals following TSST-1 stimulation, and the numbers of healthy donors studied for each co-
receptor are as indicated. Baseline values were obtained from PBMC treated with RPMI growth medium alone. To determine the inﬂuence
of IPP-activated γδT cells on receptor expression following TSST-1 stimulation, comparisons were made between IPP + TSST-1 (dashed
red lines) versus TSST-1 alone (solid black line), and signiﬁcant diﬀerences were denoted by (∗). To conﬁrm that any observed diﬀerence
in receptor expression was due to the presence of activated γδT cells, a cognate group of PBMC were depleted of γδTc e l l s( < 0.1%) and
studied in parallel experiments (b). To determine the inﬂuence of TSST-1 on IPP-activated γδT cells, comparisons were made between
IPP + TSST-1 versus IPP alone. Overnight IPP treatment signiﬁcantly up-regulated CD40 expression at 3hours and 6hours after TSST-1
stimulation (∗P<. 05, student’s t test), and down-regulated CD86 expression at 3h after TSST-1 stimulation (∗P<. 05). No other signiﬁcant
diﬀerences in receptor expression were observed for the other co-stimulatory molecules.
HMGB-1 to the cell surface where it serves a function for
process extension, migration, and cell-cell interaction [19].
Extracellular cell-surface expressed HMGB-1 has been called
amphoterin to diﬀerentiate it from intracellular HMGB-1
f o u n di nt h en u c l e u s[ 19]. Given the direct inﬂuence of γδ
T cells on the activation, maturation, and regulation of cells
of monocytic lineage [20, 21], we wanted to determine how
IPP stimulation would inﬂuence the surface manifestation
of HMGB-1 on cultured monocytes present in PBMC.
Figure 4(a) shows that resting adherent cells have HMGB-
1 (stained in green) localized at focal points around the
perimeter in vesicle-like pockets (top left corner; RPMI). T
cells, which are nonadherent cells in suspension (stained in
red), do not express HMGB-1 on the surface in this manner.
Adherent monocytes bearing surface expressed HMGB-
1 subsequently released it following TSST-1 stimulation
(Figure 4(a); top right panel). Overnight treatment with
IPP alone also led to a change in extracellular HMGB-
1 expression in PBMC cultures (Figure 4(a);b o t t o ml e f t
panel). There was an observable modiﬁcation on both the
morphological appearance of macrophages as well as the dis-
tribution of HMGB-1 around the perimeter, which became
less concentrated in vesicle-like foci and more dispersed.
Overnight incubation of PBMCs with IPP followed by TSST-
1 stimulation resulted in signiﬁcantly more HMGB-1 being
released into the extracellular environment compared to
TSST-1 alone (Figure 4(a), upper and lower right panel).
This change in surface expressed HMGB-1 was assessed
by ﬂow cytometry, which enabled us to both conﬁrm and
quantify the release of HMGB-1 from diﬀerentiated mono-
cytes following TSST-1 stimulation. Figure 4(b) displays the
diﬀerence between the various treatment conditions on the
loss of cell-surface expressed HMGB-1 assessed by ﬂow
cytometry. IPP-pretreated PBMCs that were subsequently
stimulated with TSST-1 released more HMGB-1 from the
cell surface (i.e., less HMGB-1 expression on the cell surface)
than those cells that were left untreated with IPP prior
to superantigen stimulation (IPP + TSST-1 versus TSST-
1 alone, P<. 05, paired Student’s t-test). The actual
secretion of HMGB-1 into the extracellular milieu from
TSST-1 stimulated PBMC was further veriﬁed by Western
blot of cell culture supernatants (Figure 4(c)), which again
substantiated that IPP pretreatment followed by TSST-1
stimulation led to its greater release than PBMC stimulated
with TSST-1 without IPP-activation of γδ T cells (IPP +
TSST-1versusTSST-1alone,P<. 05,pairedStudent’st-test).
4. Discussion
Overnight treatment with IPP resulted in a notable up-
regulation of CD40 on monocytes in the presence of γδ







































































































Figure 3: Modulation of CD25 and CD28 on αβ T cells by IPP-activated γδ T cells. PBMCs were cultured overnight in the presence of IPP or
absence of IPP before stimulation with 1nM of TSST-1 (a). Data (mean±SEM) for expression of CD25 and CD28 were shown after various
time intervals following TSST-1 stimulation, and the numbers of healthy donors studied for each coreceptor were as indicated. Baseline
values were obtained from PBMC treated with RPMI growth medium alone. To determine the inﬂuence of IPP-activated γδ Tc e l l so n
receptor expression, comparisons were made between IPP + TSST-1 (dashed red lines) versus TSST-1 alone (solid black line) and signiﬁcant
diﬀerences were denoted by (∗). To conﬁrm that any observed diﬀerence in receptor expression was due to the presence of activated γδ T
cells, a cognate group of PBMCs was depleted of γδ Tc e l l s( <0.1%) and studied in parallel experiments (b). To determine the inﬂuence
of TSST-1 on IPP-activated γδ T cells, comparisons were made between IPP + TSST-1 versus IPP alone, and signiﬁcant diﬀerences were
denoted by (∗∗). There was no additional eﬀect of IPP-activated γδ T cells on CD25 and CD28 expression following TSST-1 stimulation;
however, CD25 expression on αβ T cells following TSST-1 stimulation in the presence of IPP-activated γδ T cell was signiﬁcantly higher at
24 hour than with IPP alone (∗∗P = .001, student’s t-test).
CD40-CD40LinteractionwithCD40monoclonalantibodies
(but not the CD86 or CD80 interaction) completely blocks
TSST-1-induced inﬂammation [18]. The early up-regulation
of CD40 on monocytes by IPP-primed γδ T cells in the
current study provides a basis for the prior observation
that TNFα and IFNγ levels increased 3-to 4-fold during the
early phase of the immune response to TSST-1 in PBMC
containing activated γδ T cells [3]. This early augmentation
wasalsoabrogatedafterdepletionofγδ Tcells[3].Thisstudy
also demonstrates that the exaggerated response to TSST-
1b ya c t i v a t e dγδ T cells is through the direct modulation
of the responsiveness of monocytes and not αβ Tc e l l s
since we found that the upregulation of CD25 on αβ T
cells was aﬀected only by stimulation with TSST-1 and not
IPP. The regulation of CD40 expression by activated γδ T
cells appears to parallel the mechanism of linking innate
to adaptive immunity by glycolipid responsive Vα14 + NK
T cells stimulated with α-galactosylceramide. It was found
that the rapid release of TNFα and IFNγ to ovalalbumin,
acquisition of CD4+ and CD8+ T cell immunity, and
maturation of dendritic cells were all dependent on the
CD40-CD40L interaction induced by the priming of Vα14+
NK T cells by α-galactosylceramide [22]. In contrast to
CD40, CD86 expression was found to be reduced in PBMC
treated with IPP overnight. This monocytic phenotype may
be reﬂective of a state described as “immature dendritic
cells” in which cycling of the HLA-DR molecule is rapid
and levels of CD86 are relatively low [23]. Taken together,Mediators of Inﬂammation 7
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Figure 4: Change in cell surface expressed HMGB-1 (amphoterin) on adherent monocytes in PBMC following IPP and TSST-1 treatment.
(a)Fluorescentmicroscopyofsurface-expressedHMGB-1inPBMCs.HMGB-1isshowningreen,Tcellsinred,andnucleusinblue.Topleft
panel—RestingPBMCculturedoncoverslipsfor48hourswerestainedforsurfaceexpressedHMGB-1.Toprightpanel—Surfaceexpression
of HMGB-1 after 24 hour culturing in growth medium followed by 24 hour TSST-1 treatment. Bottom left panel—Surface expression of
HMGB-1 48 hours after IPP treatment. (Bottom right panel) Surface expression of PBMC that had been treated overnight with IPP and
subsequently treated with TSST-1 for 24 hour. (b) Bar graph of the ﬂow cytometry analysis quantifying the release of HMGB-1 from the cell
surface (N = 4; error bars represent SD). Statistic shown compares IPP + TSST-1 versus TSST-1 alone (P<. 05, paired Student’s t-test). (c)
Western blot analysis of secreted HMGB-1 in cultured supernatants.8 Mediators of Inﬂammation
these studies suggest that innate T lymphocytes responsive to
speciﬁc “alarmins” inﬂuence the ability of APC to eﬀectively
stimulate cells of adaptive immunity, and the CD40-CD40L
interaction likely plays a pivotal role in this process. This
scenario is in agreement with recent demonstrations that
γδ T cells induce early dendritic cell maturation and share
an intimate relationship with APC [21, 24, 25]. Eberl et al.
[26] further provided evidence that human γδ T cells are
activated by microbial mevalonate metabolites and interact
with monocytes and local macrophages to drive the acute
inﬂammationinbacterialinfections.Thus,γδ Tcellsprovide
a direct link between innate and adaptive immunity. It
should be noted, however, that these studies primarily used
either expanded γδ T cell lines or a large number of puriﬁed
γδ T cells in coculture conditions. The conditions used in
this study may be more reﬂective of the physiological state
in which a small number of γδ T cells present in peripheral
blood would be able to immediately respond to their stress-
associated antigens, such as IPP. This early event would
preclude the possibility of any expansion of γδ T cells, but
it would lead to the eﬃcient priming of APC.
ThisstudyalsoprovidestheﬁrstdemonstrationthatIPP-
primed human peripheral blood γδ T cells inﬂuence the
secretionofHMGB-1bymacrophages.Thisﬁndingissimilar
to the work by Semino et al. [27] who demonstrated that
NK cells reciprocally activate autologous dendritic cells, and
this interaction was also mediated through the secretion of
HMGB-1. It is feasible that the enhanced HMGB-1 secretion
observed in cells containing activated γδ T cells could be
in response to an increase in apoptosis [28] due to the fact
that IPP-stimulated γδ T cells are particularly susceptible
to activation-induced cell death [29, 30] as a self-limiting
precaution. During apoptosis, HMGB-1 is normally tightly
bound to nucleosomes [28] as opposed to necrosis where
HMGB-1 is released from cells [31]. However, work by
Urbonaviciute et al. [28] showed that biologically active
HMGB-1 may also be released from apoptotic cells. One of
themainligandsforextracellularHMGB-1isthereceptorfor
advanced glycation end (RAGE) products, a member of the
Ig superfamily. The expression of RAGE increases following
activation on both dendritic cells and antigen stimulated T
cells[32].ThereleaseofHMGB-1anditssubsequentbinding
to RAGE is required for the clonal expansion, survival, and
functional polarization of naive T cells [33].
Both dendritic cell maturation and Th1 polarization are
events that have been attributed to the activity of γδ Tc e l l s
andHMGB-1,respectively[21,34–36].Ourﬁndingsconnect
these two previously unrelated concepts and brings forth the
suggestion that γδ T cells mediate this eﬀect and link innate
andadaptiveimmunitybyinﬂuencingtheearlyupregulation
of CD40 expression and release of HMGB-1 from APC,
therebyprimingtheimmuneresponsetosubsequentstimuli.
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